Business and News Update March 2011

People

Alliances

• Ecron Acunova (Princeton, NJ) has entered into a joint venture with Jamjuree Innovations Thailand (Bangkok, Thailand). The joint venture CRO is based in Bangkok and will conduct clinical research in key Southeast Asian countries under the name Ecron Acunova Company Ltd.

• Merck (Whitehouse Station, NJ) and Parexel (Boston, MA) announced that they have entered into an alliance by which Parexel will provide strategic access to global clinical development services for designated biosimilar candidates to Merck BioVentures.

• Symbiance (Princeton Junction, NJ) has joined BioClinica's (Newtown, PA) Certified Partner Program.

• PharmaNet Development Group (Princeton, NJ) and Anapharm Europe (Barcelona, Spain) have ended their joint venture for the collaborative provision of bioanalytical services officially on December 22, 2010.

• Clinical Ink (Winston-Salem, NC) has entered into a partnership with ePharmaSolutions (Conshohocken, PA) to replace original paper source documents at a research site with intelligent electronic forms for use in complex psychiatric and neurological studies.

Company News

• The Association for Information and Image Management (Silver Spring, MD) has named Copernicus Group IRB (Research Triangle Park, NC) as a finalist for the 2011 Carl E. Nelson Best Practices Award, which recognizes excellence in information management.

• OmniComm Systems (Fort Lauderdale, FL) announced that its TrialOne suite of applications has been chosen by a major pharmaceutical company to automate its clinical trial operations and processes within its early-phase clinic.

• Covance's (Princeton, NJ) genomics laboratory, located in Seattle, WA, has received Clinical Laboratory Improvement Amendment certification from the State of Washington Department of Health. The laboratory received its license from the State of Washington in May 2010, and completed the initial CLIA inspection, with no findings, in December 2010.

• Metroplex Clinical Research Center (Dallas, TX) plans to expand its Phase I unit from 5,000 to 7,500 square feet in response to rising demand for early phase studies.

• Phlexglobal (Buckinghamshire, UK) has launched a new training curriculum for CRAs, CTAs, and document managers that addresses the requirement for a mix of knowledge and skills across these roles.

Mergers/Acquisitions

• CRI Worldwide (Mount Laurel, NJ) has completed the acquisition of Lifetree Clinical Research (Salt Lake City, UT), expanding CRI's clinical pharmacology capacity to more than 120 beds.

• INC Research (Raleigh, NC) has acquired the team and research products of AVOS Life Sciences (Morrisville, NC). The new division of INC Research, now called AVOS Consulting, delivers strategic, operational, and financial analysis to help life sciences companies compete in the challenging global environment.

New Facilities

• Clinical Research Advantage (Tempe, AZ) has expanded into the Colorado Springs market with the opening of two local area offices.

• Ecron Acunova (Bangalore, India) has expanded its Mangalore Clinical Pharmacology Unit to a 80 bed facility.

Products

• Phlexglobal (Buckinghamshire, UK) has enhanced its electronic Trial Master File solution, PhlexEview, with the integration of the DIA TMF Reference Model as the standard TMF structure for the system.

• PharmaVigilant (Westborough, MA) has released I-Warehouse 3.0, an enhanced version of the company's clinical data warehouse. The system gives companies a technology solution that provides immediate access to study data with comparable results.

• Biomedical Research Alliance of New York (New York, NY) has introduced "Smart-Start-60," a program that initiates clinical trials within 60 days at any of the company's certified investigator sites.

• MedPoint Communications (Evanston, IL) has released the Study Document Exchange System, a new service that optimizes the regulatory document completion process by providing a centralized platform to support the flow of documents among sites, sponsors, and CROs.

• Clinical Ink (Winston-Salem, NC) has secured an additional $2.7 million in debt and equity financing to support an electronic source record application, SureSource.

• OpenClinica (Waltham, MA) has launched a beta version of OpenClinica 3.1 that includes a completely rewritten version of Extract Data based around a plug-in architecture that increases flexibility and functionality.

• With new features designed to enhance the way biopharmaceutical and medical device companies plan, source, and track clinical trials, ClearTrial (Chicago, IL) has released ClearTrial 4.